United States (US) Next Generation Cancer Diagnostics Market (2025-2031) | Competitive Landscape, Trends, Forecast, Segmentation, Size & Revenue, Share, Value, Growth, Analysis, Outlook, Companies, Industry

Name: United States (US) Next Generation Cancer Diagnostics Market (2025-2031) | Competitive Landscape & Trends
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function (Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) And Competitive Landscape

Product Code: ETC9971448	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Next Generation Cancer Diagnostics Market Outlook
Market Size of United States (US) Next Generation Cancer Diagnostics Market, 2024
Forecast of United States (US) Next Generation Cancer Diagnostics Market, 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Revenues & Volume for the Period 2021- 2031
United States (US) Next Generation Cancer Diagnostics Market Trend Evolution
United States (US) Next Generation Cancer Diagnostics Market Drivers and Challenges
United States (US) Next Generation Cancer Diagnostics Price Trends
United States (US) Next Generation Cancer Diagnostics Porter's Five Forces
United States (US) Next Generation Cancer Diagnostics Industry Life Cycle
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Next-generation Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By qPCR & Multiplexing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Protein Microarrays for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By DNA Microarrays for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Biomarker Development for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By CTC Analysis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Proteomic Analysis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Epigenetic Analysis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Genetic Analysis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Cervical Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Function for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Therapeutic Monitoring for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Companion Diagnostics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Prognostics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Cancer Screening for the Period 2021- 2031
Historical Data and Forecast of United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume By Risk Analysis for the Period 2021- 2031
United States (US) Next Generation Cancer Diagnostics Import Export Trade Statistics
Market Opportunity Assessment By Technology
Market Opportunity Assessment By Application
Market Opportunity Assessment By Cancer
Market Opportunity Assessment By Function
United States (US) Next Generation Cancer Diagnostics Top Companies Market Share
United States (US) Next Generation Cancer Diagnostics Competitive Benchmarking By Technical and Operational Parameters
United States (US) Next Generation Cancer Diagnostics Company Profiles
United States (US) Next Generation Cancer Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Next Generation Cancer Diagnostics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Next Generation Cancer Diagnostics Market - Industry Life Cycle

3.4 United States (US) Next Generation Cancer Diagnostics Market - Porter's Five Forces

3.5 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F

3.8 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F

4 United States (US) Next Generation Cancer Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the United States

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Technological advancements in next generation sequencing and molecular diagnostics

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of new diagnostic technologies

4.3.2 High cost associated with next generation cancer diagnostics

4.3.3 Limited reimbursement policies for advanced diagnostic tests

5 United States (US) Next Generation Cancer Diagnostics Market Trends

6 United States (US) Next Generation Cancer Diagnostics Market, By Types

6.1 United States (US) Next Generation Cancer Diagnostics Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F

6.1.4 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F

6.1.5 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F

6.1.6 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F

6.1.7 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F

6.2 United States (US) Next Generation Cancer Diagnostics Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F

6.2.3 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F

6.2.4 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F

6.2.5 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F

6.2.6 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F

6.3 United States (US) Next Generation Cancer Diagnostics Market, By Cancer

6.3.1 Overview and Analysis

6.3.2 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.3.3 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.3.4 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.3.5 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F

6.3.6 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Next Generation Cancer Diagnostics Market, By Function

6.4.1 Overview and Analysis

6.4.2 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F

6.4.3 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.4.4 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F

6.4.5 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F

6.4.6 United States (US) Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F

7 United States (US) Next Generation Cancer Diagnostics Market Import-Export Trade Statistics

7.1 United States (US) Next Generation Cancer Diagnostics Market Export to Major Countries

7.2 United States (US) Next Generation Cancer Diagnostics Market Imports from Major Countries

8 United States (US) Next Generation Cancer Diagnostics Market Key Performance Indicators

8.1 Adoption rate of next generation cancer diagnostics by healthcare providers

8.2 Number of partnerships and collaborations in the field of cancer diagnostics

8.3 Rate of development and commercialization of innovative diagnostic technologies

9 United States (US) Next Generation Cancer Diagnostics Market - Opportunity Assessment

9.1 United States (US) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F

9.4 United States (US) Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F

10 United States (US) Next Generation Cancer Diagnostics Market - Competitive Landscape

10.1 United States (US) Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 United States (US) Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Next Generation Cancer Diagnostics Market

El Salvador Next Generation Cancer Diagnostics Market

Equatorial Guinea Next Generation Cancer Diagnostics Market

Eritrea Next Generation Cancer Diagnostics Market

Estonia Next Generation Cancer Diagnostics Market

Ethiopia Next Generation Cancer Diagnostics Market

Global Next Generation Cancer Diagnostics Market

Middle East Next Generation Cancer Diagnostics Market

North America Next Generation Cancer Diagnostics Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here